Search for: "KYLE PRICE"
Results 181 - 200
of 310
Sort by Relevance
|
Sort by Date
2 Dec 2015, 9:10 am
If effective labeling motivates this minority of law schools to act responsibly, then the hurt feelings of a few people associated with these schools is a small price to pay. [read post]
16 Nov 2015, 3:49 am
He also passed on information to journalist Greig Box Turnbull about life at the high security jail which resulted in stories about Easter eggs, a laptop for a terror suspect and higher prices in the prison canteen. [read post]
14 Nov 2015, 4:09 am
The line-up of experts and panellists in Santa Clara was diverse and impressive, and included people like Internet Archive founder Brewster Kahle, Ted Ullyot, who works for the technology investment firm of Andreessen Horowitz, musician Zoe Keating, iFixit CEO and DMCA activist Kyle Wiens, and of course EFF's own staff attorney Kit Walsh.U.S. [read post]
10 Nov 2015, 1:14 pm
Kyle McEntee (Law School Transparency), Price Discrimination Will Ultimately Bite Law Schools: Our investigation into law school admissions practices and trends has sent shock waves through the legal profession. [read post]
26 Oct 2015, 4:37 pm
"[67] A few after Clinton's tweet, Valeant lost nearly 20%, "a significant portion of its valuelink to Wikipedia: https://en.wikipedia.org/wiki/Valeant_PharmaceuticalsNow, if a politician sold short on a pharma stock, and then criticized the pharma the next day, is that any different fromthe Kyle Bass IPR strategy? [read post]
18 Oct 2015, 8:28 pm
The only place online that one can find a more extensive and scholarly treatment of the Aruba case is on The Chancery Daily, which is available by subscription–and is well worth the price. [read post]
15 Oct 2015, 9:01 am
SeekingAlpha talked about the price drop in Biogen sharesIts EVP of sales has resigned suddenly with no successor, and a competitor unveiled strong data on its late-stage pipeline candidate, ocrelizumab. link: http://seekingalpha.com/article/3568226-biogen-drops-again-a-reassessment-of-the-bull-and-bear-investment-cases***One notes the general downward trend was seemingly NOT influenced by the IPR petition by Kyle Bass on Tecfidera, which petition ultimately was not granted. [read post]
12 Oct 2015, 12:22 am
Shire’s price fell after the decision. [read post]
10 Sep 2015, 5:04 am
The protocol should look something like this: Hello, I’m Jan with the law offices of Kyle Krull. [read post]
5 Sep 2015, 11:58 am
“Hedge-fund manager Kyle Bass isn’t taking his early losses to the drug industry lightly. [read post]
31 Aug 2015, 7:21 am
Chris Versace (with a position at New Jersey City University (NJCU)) criticizes pharma industry proposals on IPRs, without mentioning the forays of Kyle Bass: According to a Politico report, “The drug industry is circulating a sign-on letter to build support for exempting drugs from a streamlined patent challenge process, a key issue stalling the House’s Innovation Act. [read post]
22 Aug 2015, 1:48 pm
His target has been pharmaceutical patents which he says have little value save for increasing the price of prescription drugs. [read post]
3 Aug 2015, 2:48 pm
Since production costs are minimal, there is pressure to sell them at low prices and release generic versions. [read post]
17 Jul 2015, 7:39 am
Senator Stevens was charged with corruption for accepting the services of a building contractor and paying him far below market price — essentially a bribe. [read post]
14 Jun 2015, 7:30 pm
By challenging the patents, he argues that drug prices can be lowered.Link: http://blogs.wsj.com/pharmalot/2015/04/02/innovate-or-else-kyle-bass-strikes-again-and-challenges-shire-patents/ [read post]
7 Jun 2015, 9:43 am
**Acorda stock did drop around 10% after Kyle Bass filed an IPR against patent claims related Acorda's MS drug Ampyra (active ingredient 4-amino pyridine). [read post]
6 Jun 2015, 10:25 am
After seeing patent reform fail twice in five years, the coalition may prefer to walk away than to grant a concession that would amount to giving away as much as it gets, said the person who spoke on condition of anonymity.As to the issue of third parties using IPR to manipulate stock prices, Roberts is disingenuouly silent over the stock swing Acorda faced when Ampyra was challenged by Kyle Bass:The Bass challenge does not appear to have dented Jazz’s stock, but just the… [read post]
4 May 2015, 10:00 pm
In the few weeks since I first wrote about Kyle Bass and the Coalition for Affordable Drugs he formed to challenge Orange Book-listed patents that he believes “have little value other than to drive up prescription drug prices,” he has been busy. [read post]
29 Apr 2015, 7:50 am
The economies of legal software applications will enable lawyers to make a living offering legal services to persons now priced out of the legal services market. [read post]
24 Apr 2015, 2:52 am
Kyle Bass is involved in at least five IPRs against drug patents.It is suspected his interests are shorting the stock of the target companies prior to filingthe IPR, in anticipation of a stock price drop. [read post]
